Nephrocare Health Services LimitedNEPHROPLUSCorporate

Healthcare Service Provider Latest results: Jun 2026 6 quarters of data

₹614.35

MCap ₹6,178 Cr

Nephrocare Health Services Limited — Stock analysis & AI research Nephrocare Health Services Limited — Multibagger AI analysis Nephrocare Health Services Limited — Seasonality — best & worst months Nephrocare Health Services Limited — Technical indicators & charts Nephrocare Health Services Limited — Technical setup — score, trend, support & resistance Nephrocare Health Services Limited — Live exchange announcements

📋 Stocks With Strong Quarterly Results 📈 RSI Oversold Stocks 🏭 Healthcare sector

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹170 Cr

Sales · Jun 2026

+14.3% YoY

₹24 Cr

Operating Profit · Jun 2026

+20.7% YoY

14.2%

OPM % · Jun 2026

+6.0% YoY

₹13 Cr

Net Profit · Jun 2026

+151.3% YoY

₹1.25

EPS · Jun 2026

-54.9% YoY

📝 Nephrocare Health Services Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Nephrocare Health Services Limited reported revenue of ₹170 crore for the quarter ended June 2026 (Q1 FY27), up 14.3% from ₹149 crore in the same quarter last year, and up 3.9% sequentially over the March 2026 quarter.

Net profit rose 151.3% year-on-year to ₹13 crore, from ₹5 crore. Earnings per share (EPS) came in at ₹1.25.

Operating profit stood at ₹24 crore — an operating margin (OPM) of 14.2%, compared with 13.4% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Nephrocare Health Services Limited posted revenue of ₹630 crore, with a net loss of ₹8 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹651 crore with a net loss of ₹0 crore.

Valuation snapshot

At the current price of ₹614.35, NEPHROPLUS has a market capitalisation of ₹6,178 crore.

Within the Healthcare Service Provider industry, it is the largest of the 20 companies we track by market value.

Shareholding pattern

As of Sep 2026, promoters held 58.31%, foreign institutional investors (FIIs) 11.73%, domestic institutional investors (DIIs) 8.11%, public shareholders 21.85% of Nephrocare Health Services Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹6,178 Cr

Current Price ?

₹614.4

P/E ?

N/A

Industry P/E ?

22.50

P/B ?

N/A

P/S ?

9.48

P/FCF ?

N/A

Enterprise Value ?

N/A

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

N/A

Dividend Yield ?

N/A

Profitability & Returns

Sales (TTM) ?

₹651 Cr

OPM ?

14.1%

Profit after tax (TTM) ?

₹-0 Cr

EPS (TTM) ?

₹-0.04

ROCE ?

N/A

ROE ?

N/A

ROA ?

N/A

Growth

Sales — latest qtr ?

₹170 Cr

PAT — latest qtr ?

₹13 Cr

YoY qtr sales growth ?

14.3%

YoY qtr profit growth ?

151.3%

Sales growth (3y) ?

N/A

Sales growth (5y) ?

N/A

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

N/A

Debt to Equity ?

N/A

Interest Coverage ?

0.6

Current Ratio ?

N/A

Ownership

Promoter holding ?

58.31%

Change in promoter holding ?

0.00%

Pledged percentage ?

N/A

Market

Return 3 months ?

-3.4%

Return 6 months ?

4.9%

🗓️ Quarterly results (6 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	145	149	156	161	164	170	+14.3%	+3.9%
Operating Profit	22	20	23	23	22	24	+20.7%	+9.7%
Other Income	3	3	3	3	6	6	+104.1%	+2.1%
Interest	4	3	41	4	1	0	-83.8%	-51.5%
Depreciation	13	12	16	13	16	13	+9.1%	-18.2%
Profit Before Tax	7	7	-31	9	11	17	+138.5%	+51.8%
Net Profit	6	5	-32	8	11	13	+151.3%	+14.2%
EPS	27.20	2.77	-17.92	0.84	1.09	1.25	-54.9%	+14.7%
OPM %	15.2%	13.4%	14.7%	14.3%	13.4%	14.2%	+6.0%	+6.0%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	Prev FY	FY26	TTM	YoY %
Sales	—	₹630 Cr	₹651 Cr	—
Operating Profit	—	₹88 Cr	₹92 Cr	—
OPM %	—	13.97%	14.15%	—
NPM %	—	-1.27%	-0.07%	—
Other Income	—	₹15 Cr	₹18 Cr	—
Depreciation	—	₹57 Cr	₹58 Cr	—
Interest	—	₹49 Cr	₹46 Cr	—
EBIT	—	₹31 Cr	₹34 Cr	—
PBT	—	₹-4 Cr	₹6 Cr	—
Tax	—	—	₹4 Cr	—
Net Profit	—	₹-8 Cr	₹-0 Cr	—
EPS	—	₹-13.22	₹-14.74	—
Material Cost	—	—	₹42 Cr	—
Employee Cost	—	—	₹31 Cr	—
Extraordinary Items	—	—	—	—

👥 Shareholding (latest 1 periods)

Metric	Sep 2026	% Chg
Promoters	58.31%	—
FIIs	11.73%	—
DIIs	8.11%	—
Public	21.85%	—
No. of Shareholders	56,735	—

⚖️ Peer comparison

Industry: Healthcare Service Provider · 20 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	NEPHROPLUS Nephrocare Health	₹673.00	6,768	78.9	1,054	85	22.8%	8.1%	—	—	23.6%	33.2%
2	532067 3B BlackBio	₹1,205.90	1,166	18.8	153	56	34.9%	36.7%	47.1%	25.7%	50.7%	-29.0%
3	514330 One Global	₹139.00	1,043	3.7	513	74	19.1%	14.5%	311.6%	288.9%	16.8%	43.0%
4	HEALTHX Health X	₹306.95	976	—	0	-1	-390.4%	-376.2%	—	—	-20.0%	-367.5%
5	526546 Choksi Laboratories	₹61.93	146	19.9	47	2	26.8%	4.6%	10.1%	28.8%	7.5%	49.3%
6	540788 Aspira Pathlab	₹31.00	107	—	26	-0	3.8%	-1.7%	13.5%	-97.1%	17.5%	-108.5%
7	530897 NG Industries	₹165.30	39	28.7	17	2	11.1%	11.4%	-0.9%	-77.7%	13.8%	104.3%
8	524602 Bandaram Pharma	₹30.99	33	162.8	79	1	4.8%	1.5%	70.2%	-46.9%	195.7%	3322.0%
9	524548 Sharma East	₹50.09	32	13.9	37	1	9.6%	3.2%	20.3%	0.0%	13.7%	-18.7%
10	542248 Deccan Health	₹35.53	30	34.8	82	3	6.4%	3.1%	9.1%	115.7%	-0.3%	21.3%
11	539267 Samsrita Labs	₹17.13	28	—	—	—	—	—	—	—	—	—
12	523489 Chennai Meenakshi	₹34.47	28	—	37	-0	1.5%	-1.1%	6.4%	16.1%	-0.7%	100.4%
13	539428 Tejnaksh Healthcare	₹23.46	27	38.5	11	1	26.5%	11.3%	-16.3%	-47.5%	0.5%	24.1%
14	526139 Transgene Biotek	₹9.56	21	—	0	-2	-223.0%	-766.2%	-25.9%	-146.3%	20.0%	9.5%
15	516110 Family Care	₹7.44	11	—	0	-8	-1321.3%	-3505.7%	-97.3%	80.3%	150.0%	39.5%
16	534422 Looks Health	₹5.73	10	177.4	0	0	41.2%	7.5%	-2.6%	0.0%	75.7%	—
17	531043 Dhanvantri Jeevan	₹19.95	10	16.1	28	1	3.2%	1.8%	14.2%	-23.5%	41.6%	200.0%
18	526504 Dolphin Medical	₹1.85	10	5.2	1	0	13.0%	7.4%	-2.6%	333.3%	21.2%	-40.7%
19	541299 Dr Lalchandani	₹27.60	7	345.0	4	0	9.3%	1.7%	—	—	-8.6%	-148.1%
20	526187 Ashram Online.Com	₹6.29	7	—	1	-0	-74.9%	-20.3%	33.3%	-71.4%	31.6%	40.2%

❓ Frequently asked questions

What was Nephrocare Health Services Limited's revenue in Q1 FY27?

What was Nephrocare Health Services Limited's net profit in Q1 FY27?